These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12450669)

  • 1. Separation methods for catechol O-methyltransferase activity assay: physiological and pathophysiological relevance.
    Pihlavisto P; Reenilä I
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Dec; 781(1-2):359-72. PubMed ID: 12450669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular recognition at the active site of catechol-O-methyltransferase (COMT): adenine replacements in bisubstrate inhibitors.
    Ellermann M; Paulini R; Jakob-Roetne R; Lerner C; Borroni E; Roth D; Ehler A; Schweizer WB; Schlatter D; Rudolph MG; Diederich F
    Chemistry; 2011 May; 17(23):6369-81. PubMed ID: 21538606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of catechol-O-methyltransferase in catechol-enhanced erythroid differentiation of K562 cells.
    Suriguga ; Li XF; Li Y; Yu CH; Li YR; Yi ZC
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):635-43. PubMed ID: 24141029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-dopa upregulates the expression and activities of methionine adenosyl transferase and catechol-O-methyltransferase.
    Zhao WQ; Latinwo L; Liu XX; Lee ES; Lamango N; Charlton CG
    Exp Neurol; 2001 Sep; 171(1):127-38. PubMed ID: 11520127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacophore-based virtual screening of catechol-o-methyltransferase (COMT) inhibitors to combat Alzheimer's disease.
    Patel CN; Georrge JJ; Modi KM; Narechania MB; Patel DP; Gonzalez FJ; Pandya HA
    J Biomol Struct Dyn; 2018 Nov; 36(15):3938-3957. PubMed ID: 29281938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic reaction mechanism for magnesium binding to membrane-bound and soluble catechol O-methyltransferase.
    Jeffery DR; Roth JA
    Biochemistry; 1987 May; 26(10):2955-8. PubMed ID: 3607001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospecting for new catechol-
    da Silva IR; Parise MR; Pereira M; da Silva RA
    J Biomol Struct Dyn; 2021 Oct; 39(16):5872-5891. PubMed ID: 32691671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O-Methylation of tea polyphenols catalyzed by human placental cytosolic catechol-O-methyltransferase.
    Zhu BT; Patel UK; Cai MX; Conney AH
    Drug Metab Dispos; 2000 Sep; 28(9):1024-30. PubMed ID: 10950844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The extra virgin olive oil phenolic oleacein is a dual substrate-inhibitor of catechol-O-methyltransferase.
    Cuyàs E; Verdura S; Lozano-Sánchez J; Viciano I; Llorach-Parés L; Nonell-Canals A; Bosch-Barrera J; Brunet J; Segura-Carretero A; Sanchez-Martinez M; Encinar JA; Menendez JA
    Food Chem Toxicol; 2019 Jun; 128():35-45. PubMed ID: 30935952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catechol-o-methyltransferase biochemical genetics: human lymphocyte enzyme.
    Sladek-Chelgren S; Weinshilboum RM
    Biochem Genet; 1981 Dec; 19(11-12):1037-53. PubMed ID: 7337686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme.
    Lotta T; Vidgren J; Tilgmann C; Ulmanen I; Melén K; Julkunen I; Taskinen J
    Biochemistry; 1995 Apr; 34(13):4202-10. PubMed ID: 7703232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solubilization and partial purification of particulate catechol-O-methyltransferase from rat liver.
    Tong JH; D'Iorio A
    Can J Biochem; 1977 Oct; 55(10):1108-13. PubMed ID: 912603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal Structure of Catechol O-Methyltransferase Complexed with Nitecapone.
    Iijima H; Takebe K; Suzuki M; Kobayashi H; Takamiya T; Saito H; Niwa N; Kuwada-Kusunose T
    Chem Pharm Bull (Tokyo); 2020; 68(5):447-451. PubMed ID: 32378542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicinal chemistry of catechol O-methyltransferase (COMT) inhibitors and their therapeutic utility.
    Kiss LE; Soares-da-Silva P
    J Med Chem; 2014 Nov; 57(21):8692-717. PubMed ID: 25080080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [6.7-Dihydroxycoumarin (Aesculetin) as a substrate for catechol-o-methyltransferase (author's transl)].
    Müller-Enoch D; Seidl E; Thomas H
    Z Naturforsch C Biosci; 1976; 31(5-6):280-4. PubMed ID: 134569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catechol O-methyltransferase pharmacogenetics: photoaffinity labelling and western blot analysis of human liver samples.
    Aksoy S; Klener J; Weinshilboum RM
    Pharmacogenetics; 1993 Apr; 3(2):116-22. PubMed ID: 8518836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of Potent and Druglike Nonphenolic Inhibitors for Catechol O-Methyltransferase Derived from a Fragment Screening Approach Targeting the S-Adenosyl-l-methionine Pocket.
    Lerner C; Jakob-Roetne R; Buettelmann B; Ehler A; Rudolph M; Rodríguez Sarmiento RM
    J Med Chem; 2016 Nov; 59(22):10163-10175. PubMed ID: 27685665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catechol-O-methyltransferase and Parkinson's disease.
    Tai CH; Wu RM
    Acta Med Okayama; 2002 Feb; 56(1):1-6. PubMed ID: 11873938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydroxynitrobenzaldehydes and hydroxymethoxynitrobenzaldehydes: synthesis and biological activity as catechol-O-methyltransferase inhibitors.
    Pérez RA; Fernández-Alvarez E; Nieto O; Piedrafita FJ
    J Med Chem; 1992 Nov; 35(24):4584-8. PubMed ID: 1469689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and kinetic mechanism of human brain soluble catechol-O-methyltransferase.
    Jeffery DR; Roth JA
    J Neurochem; 1985 Mar; 44(3):881-5. PubMed ID: 3973595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.